Evidence map›Paper›PMID 17200190›Full record

ArticleThe American journal of pathology2007

Pre-B-cell leukemia transcription factor 1 regulates expression of valosin-containing protein, a gene involved in cancer growth.

Ying Qiu, Yasuhiko Tomita, Binglin Zhang, Itsuko Nakamichi, Eiichi Morii, Katsuyuki Aozasa

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Maternal pre-conceptional glyphosate exposure impacts the offspring hepatic and ovarian proteome.Toxicological sciences : an official journal of the Society of Toxicology · 2023
    Article
  3. Research progress of PBX1 in developmental and regenerative medicine.International journal of medical sciences · 2023
    Review
  4. The regulation of PBXs and their emerging role in cancer.Journal of cellular and molecular medicine · 2022
    Review
  5. PBX1: a key character of the hallmarks of cancer.Journal of molecular medicine (Berlin, Germany) · 2021
    Review
  6. Article
  7. Article
  8. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2013
    Article
  9. Article
  10. Article
  11. Article
  12. The Hox genes and their roles in oncogenesis.Nature reviews. Cancer · 2010
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Ying QiuDepartment of Pathology, Medical School of Tongji University, Shanghai, China.
Yasuhiko Tomita
Binglin Zhang
Itsuko Nakamichi
Eiichi Morii
Katsuyuki Aozasa
Osaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Valosin-containing protein (VCP) is involved in a wide variety of cellular functions. Our previous studies showed that the enhanced expression of VCP in cancer cells correlated with invasion and metastasis of cancers. Here, the regulatory mechanism for VCP transcription was investigated. Luciferase reporter constructs containing serially deleted 5'-flanking region of the VCP gene were transfected into MCF7 mammary carcinoma cell line, in which VCP was abundantly expressed. The deletion and mutation at the two binding motifs for pre-B-cell leukemia transcription factor 1 (PBX1) reduced the luciferase activity, indicating that these two PBX1 motifs mediated the transactivation of the VCP gene. Chromatin immunoprecipitation assay showed the binding of PBX-1 to the 5'-flanking region of the VCP gene. The knockdown of PBX1 by siRNA decreased the expression level of VCP. VCP is reported to maintain cell viability after the treatment of tumor necrosis factor-alpha. The viability of tumor necrosis factor-alpha-treated cells was significantly reduced in PBX1 knockdown MCF7. These findings indicate that PBX1 plays a crucial role in VCP expression and function and that the PBX-VCP pathway might be important for cell survival under cytokine stress.

Indexed as

Gene Expression Regulation, Neoplastic5' Flanking RegionAdenosine TriphosphatasesCell Cycle ProteinsCell Line, TumorCell SurvivalDNA-Binding ProteinsFemaleHumansMaleMutagenesis, Site-DirectedNeoplasmsPre-B-Cell Leukemia Transcription Factor 1Proto-Oncogene ProteinsRNA, Small InterferingSequence DeletionAdenosine TriphosphatasesCell Cycle ProteinsDNA-Binding ProteinsPBX1 protein, humanPre-B-Cell Leukemia Transcription Factor 1Proto-Oncogene ProteinsRNA, Small InterferingTumor Necrosis Factor-alphaValosin Containing ProteinVCP protein, human

Identifiers

PMID17200190
PMCPMC1762682
OpenAlexW1973217696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.